Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Phase II study demonstrates prognostic value of uPAR-PET in head and neck cancer patients

Results from an investigator-initiated phase II study performed by researchers at Rigshospitalet and using the uTRACE[®] technology have now been published online ahead of print in the prestigious Journal of Nuclear Medicine. The abstract of the article is freely available here .The phase II study The phase II trial (NCT02965001) aimed to evaluate the prognostic value of uPAR-PET with [68]Ga-NOTA-AE105 (uTRACE[®]) in head and neck cancer and compare it to FDG-PET. A total of 57 patients referred to radiotherapy were included and followed for a

Hansa Biopharma: Issue and repurchase of class C shares for incentive programs

Lund December 9, 2021. The board of directors of Hansa Biopharma AB (publ) (“Hansa”), (Nasdaq Stockholm: HNSA) today resolved to issue 440,452 new class C shares and to immediately thereafter repurchase such 440,452 issued class C shares. Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on 12 May 2021. Svenska Handelsbanken AB (publ) will subscribe for all issued class C shares at a subscription price of SEK one (1) per share. All 440,452 issued class C shares will be repurchased by Hansa at a purchase price of

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 09.12.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 09.12.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 09.12.2021 Date 09.12.2021Exchange transaction BuyShare class ALEXAmount 409Average price/share 8.2100 EURHighest price/share 8.2100 EURLowest price/share 8.2100 EURTotal price 3,357.89 EUR The shares held by Alexandria Pankkiiriliike Oyj on 09.12.2021: ALEX 42,718 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Terveystalo Plc: SHARE REPURCHASE 9.12.2021

Terveystalo Plc ANNOUNCEMENT  9.12.2021 Terveystalo Plc: SHARE REPURCHASE 9.12.2021 In the Helsinki Stock Exchange Trade date           9.12.2021Bourse trade         BuyShare                  TTALOAmount             24 101 SharesAverage price/ share    11,1841 EURTotal cost            269 547,99 EUR Terveystalo Plc now holds a total of 1 391 269 sharesincluding the shares repurchased on 9.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

YA Holding successfully issues social sustainability-linked bonds

YA Holding AB (publ) (“YA” or the “Company”) successfully issues senior secured social sustainability-linked bonds in an amount of SEK 480 million within a framework of SEK 650 million (the “Bonds”). The Bonds have a floating interest rate of 3m Stibor + 875 basis points and mature on 17 December 2024. The issue generated strong interest and the final orderbook was oversubscribed. The net proceeds from the Bonds shall be applied towards redemption in full of the Company’s outstanding bonds (ISIN SE0005990835) (“Existing Bonds”) and applied towards general corporate purposes, including

Össur hf: CEO Retirement and Succession Plan

Announcement no. 18/2021 9 December 2021 Jon Sigurdsson to retire after 26 years as Össur President and CEO, Sveinn Sölvason appointed President and CEO successor Jon Sigurdsson has decided to retire from his position as President and CEO of Össur. The Board of Directors has appointed Össur CFO, Sveinn Sölvason, to succeed as President and CEO effective 1 April 2022. “On behalf of the Board of Directors, the executive management team, and Össur’s 4,000 employees, we want to sincerely thank Jon for his leadership over his more than two and a half decades with the Company,” said

Bluestep Bank AB (publ) has completed a tap issue of SEK 300 million of the senior unsecured bond loan maturing in April 2024

Loan number: 6 Tranche number: 3 ISIN: SE0013102092 Loan date: 16 December 2021 Maturity date: 8 April 2024 Tap volume: SEK 300 million Aggregate outstanding loan amount after the tap: SEK 1 050 million Price: 100.426% plus accrued interest Re-offer spread: 3m Stibor + 0.47% Lead manager: SEB   For more information, please contact: Klas Lavemark, Head of Treasury +46 70 547 5174 Or visit www.bluestepbank.com

Endomines resolves on a directed share issue to LDA Capital Limited

Endomines resolves on a directed share issue to LDA Capital Limited Endomines AB (publ), Stock Exchange Release 9 December 2021 at 17:00 CET   The Board of Directors of Endomines AB (publ) ("Endomines" or the "Company") has, based on the authorisation granted by the Annual General Meeting on 10 June 2021, resolved on a directed issue of 2,673,911 shares to LDA Capital Limited ("LDA") at a price of EUR 0.245 (corresponding to SEK 2.510[1]) per share (the “Directed Issue”), providing total issue proceeds of EUR 655,108 (corresponding to SEK 6,711,1231). The proceeds from the Directed

Sandvik completes the acquisition of screens and feeders manufacturer Kwatani

Sandvik has completed the previously announced acquisition of the South African based company Kwatani, a leading supplier of screens and feeders for the mining industry. The product offering includes screens, feeders, fine separators, drives and services. In 2020 Kwatani had revenues of about 175 million SEK and an EBIT margin slightly dilutive to Sandvik Rock Processing Solutions. Impact on Sandvik’s earnings per share will initially be neutral. The company will be reported in Stationary Crushing and Screening, a division in Sandvik Rock Processing Solutions. Stockholm, December 9,

CS MEDICA A/S: Notice of Shareholders Annual Meeting

Today on December 9, 2021, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or the ”Company”) held its annual general meeting (“AGM”) at which the following principal resolutions were passed.Presentation of the annual report with auditors’ report for adoptionThe AGM resolved in accordance with the Board of Directors’ proposal, to approve the annual report presented during the AGM. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual reportThe AGM resolved, in accordance with the Board of Directors’ proposal, that the result for the period 1 October

EAB Group Plc: Changes to the key employees’ Performance Share Plan

EAB Group Plc, Stock Exchange Release, 9 December 2021, 5:40 p.m. (EET) EAB Group Plc: Changes to the key employees’ Performance Share Plan The Board of Directors of EAB Group Plc has decided 9 December 2021 to change the key employees’ Performance Share Plan. The Board of Directors decided 7 August 2020 to establish a new share-based incentive plan for the Group key employees. The introduction of the plan and the key terms and conditions have been announced in a stock exchange release 7 August 2020. The Board of Directors has decided on the details of the new performance period of

AddLife announces senior management change

AddLife has made changes to its Group Management Team, with Martin Almgren stepping down as CFO to become Head of the Medtech business area. Martin succeeds Ove Sandin, who will take over the role of Senior Advisor. Christina Rubenhag has been recruited as the new CFO and will join during the second quarter of 2022. Ove Sandin has on his own initiative chosen to leave the role of Business Area Manager for Medtech and transfer to the role of Senior Advisor. Ove Sandin has been a member of Group Management since 2019 and has prior to that been active in several roles within the Group.

Excillum launches the NanoTube N3 – the highest X-ray resolution up to 160 kV

Excillum  today announces the launch of their latest development – a new generation high-resolution X-ray tubes. The Excillum NanoTube N3 , initially available in 3 different versions, enables the world’s best resolution up to 160 kV.“We are very excited to launch our latest development, the NanoTube N3, that will provide both industries and research facilities with an on-premise X-ray source with unprecedented resolution across the full voltage range. TheNanoTube N3 will open up new possibilities for all

Cyxone files patent application with potential to extend market exclusivity of the drug candidate Rabeximod

Cyxone (publ) today announces that the company has filed a new patent application for Rabeximod with patent authorities in key strategic territories. Approval of this new patent application on these markets, in conjunction with four additional patents filed during the period 2020–2021, will strengthen the intellectual property portfolio for Rabeximod and elongate the market exclusivity period until at least 2043.Rabeximod is a well-tolerated, orally available Phase 2 drug candidate that selectively targets the inflammatory macrophage – the central orchestrator of the inflammatory process.

Dignitana AB Appoints Nomination Committee

Dignitana , world leader in scalp cooling innovation, has appointed the Nomination Committee for the 2022 Annual General Meeting to be held 25 May 2022. The Nomination Committee will consist of Greg Dingizian, Chairman of the Board and Owner of Adma Förvaltnings AB on closely related company’s mandate; Bo Lundgren, appointed by Swedbank Robur AB on closely related company mandate; and Klas Arildsson, Chairman of the Board of Dignitana AB. The nomination committee shall give proposals for chairman at the AGM, election and remuneration of board members and,

Wulff Group Plc’s financial reporting and annual general meeting 2022

STOCK EXCHANGE RELEASE | DECEMBER 9, 2021 AT 17.00 P.M. Wulff Group Plc will release the following financial reports in 2022: Financial Statements Release 2021 Monday February 21, 2022Annual Report Thursday March 10, 2022Interim Report January-March 2022 Monday April 25, 2022Half-Year Report January-June 2022 Monday July 25, 2022Interim Report January-September 2022 Monday October 24, 2022 The release time is approximately 9:30 a.m. on the release date. The Annual General Meeting of Wulff Group Plc will be held on Friday April 8,

Latour divests its shares in Neuffer Fenster + Türen GmbH

Investment AB Latour has, through its fully owned subsidiary Latour-Gruppen AB, signed an agreement to divest its shares in Neuffer Fenster + Türen GmbH (“Neuffer”) to IFN-Holding AG (“IFN”), based in Traun, Austria. The completion of the transaction is expected to take place during the month of January 2022, subject to customary closing conditions. Neuffer is a company active in the distribution, development and installation of windows and doors through online sales and Latour acquired 66 per cent of the shares in Neuffer in 2015 in order to gain additional competence and knowledge

SOTKAMO SILVER AB: UPDATED GUIDANCE FOR SILVER PRODUCTION IN 2021

Press release: Stockholm, December 9, 2021, 16:00 CET Sotkamo Silver AB updates the estimate for silver production in 2021. We estimate that the annual silver production in 2021 will be ca 1.38 million ounces. In December we shall feed more than planned of marginal ore to the concentrating plant due to the delay of the open pit mining from the earlier schedule. Consequently, the annual silver production in 2021 is estimated to be slightly below the earlier production guidance. Updated production guidance for 2021: We estimate that the annual silver production in 2021 will be ca.

IAR Systems appoints Richard Lind as CEO

The board of I.A.R. Systems Group has, after an evaluation, concluded that Richard Lind is very well suited to lead IAR Systems towards new growth and has today decided to appoint Richard Lind as permanent CEO.Stockholm, Sweden — December 9, 2021 — Richard Lind is a former CTO for Internet of Things (IoT) at Microsoft. In addition, he has held international management positions within sales and marketing, and was responsible for the market introduction of Azure Cloud at Microsoft Sweden. Richard has substantial industry experience and has been very well received by the employees since

Sinch completes the acquisition of Inteliquent

Stockholm, Sweden – December 9, 2021 – Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, today announces that the acquisition of Inteliquent has been completed. The acquisition of Inteliquent positions Sinch as the largest independent provider of voice services to both enterprises and telecom carriers in the United States. The Inteliquent platform handles more than 300 billion minutes of voice calling per year and the company has registered more than 115 million active phone numbers on behalf of its customers. Superior quality is guaranteed by a

IFS Named a Leader in The Forrester Wave™ 2021: Enterprise Service Management (ESM)

IFS received highest possible score for product vision, commercial model, deployment, and enterprise service capabilitiesLondon, UK - December 9, 2021 - IFS , the global cloud enterprise software company, today announced it has been named a Leader in The Forrester Wave™ 2021: Enterprise Service Management (ESM) , Q4 2021 report by Forrester Research, Inc.IFS entered the ESM space with its

Omnicar announces notice convening an extraordinary general meeting

The board of directors of OmniCar Holding AB (“OmniCar” or the “Company”) has today resolved to convene an extraordinary general meeting (the “EGM”) on December 28, 2021 and propose to the EGM (i) that OmniCar’s CEO Claus T. Hansen and Kevin Magnussen shall replace Mikkel Lippmann and Jens Sørensen on the Company’s Board as previously announced, (ii) that the EGM resolves on the previously announced issue of shares to the underwriters of the series TO2 subscription warrants, and (iii) an authorisation for the board of directors to issue shares. The full notice for the EGM, including the

Photocure ASA: Share capital increase registered

Oslo, Norway, 9 December 2021: Reference is made to the stock exchange release by Photocure ASA ("Photocure" or the "Company") published on 3 December 2021 regarding a share capital increase following the exercise of share options.The issuance of 30,000 new shares has been registered with the Norwegian Register of Business Enterprises. Following registration, the share capital of Photocure is NOK 13,486,910 divided into 26,973,820 shares, each share having a par value of NOK 0.50 and carrying one vote in the Company's general meeting. For further information, please contact:Photocure

There are no items matching the current filter
There are no more items matching the current filter
Back to top